Download PDF
Semin Respir Crit Care Med 2023; 44(02): 217-224
DOI: 10.1055/s-0042-1758730
Review Article

Impact of Digital Technologies on Clinical Care for Adults with Cystic Fibrosis

Daniel Peckham
1   Leeds Adult Cystic Fibrosis Unit, St James's University Hospital, Leeds, United Kingdom
2   Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom
,
Giulia Spoletini
1   Leeds Adult Cystic Fibrosis Unit, St James's University Hospital, Leeds, United Kingdom
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

The coronavirus disease 2019 pandemic accelerated the implementation of digital technologies, which have now become embedded as essential tools for the management of chronic disease, including cystic fibrosis (CF). Despite subsequent easing of restrictions and because of improved clinical stability resulting from the introduction of highly effective modulator therapy, digital technologies including video and telephone consultations and remote monitoring are likely to remain integral to the future delivery of CF health care. In this article, we explore some of the key developments in digital technologies, barriers to their adoption, and how the CF community is likely to embrace lessons learned from the recent pandemic to help modernize and reshape the future of CF care.

Keywords

cystic fibrosis - COVID-19 - video consultation - telemedicine - adherence


Publication History

Article published online:
19 December 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Keesara S, Jonas A, Schulman K. Covid-19 and health care's digital revolution. N Engl J Med 2020; 382 (23) e82
    CrossrefPubMedGoogle Scholar
  • 2 Peckham D. Electronic patient records, past, present and future. Paediatr Respir Rev 2016; 20 (suppl): 8-11
    PubMedGoogle Scholar
  • 3 Costa RLF, Costa RF, Gonçalves CP, Cohen RWF, Santana NN. Telemedicine of patients with cystic fibrosis during the COVID-19 pandemic. Rev Paul Pediatr 2022; 40: e2021118 (In engpor).
    CrossrefPubMedGoogle Scholar
  • 4 Rodkjær L, Jeppesen M, Schougaard L. Management of cystic fibrosis during COVID-19: patient reported outcomes based remote follow-up among CF patients in Denmark—a feasibility study. J Cyst Fibros 2022; 21 (02) e106-e112
    CrossrefPubMedGoogle Scholar
  • 5 Compton M, Soper M, Reilly B. et al. A feasibility study of urgent implementation of cystic fibrosis multidisciplinary telemedicine clinic in the face of covid-19 pandemic: single-center experience. Telemed J E Health 2020; 26 (08) 978-984
    CrossrefPubMedGoogle Scholar
  • 6 Middleton PG, Mall MA, Dřevínek P. et al; VX17-445-102 Study Group. Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele. N Engl J Med 2019; 381 (19) 1809-1819
    CrossrefPubMedGoogle Scholar
  • 7 Heijerman HGM, McKone EF, Downey DG. et al; VX17-445-103 Trial Group. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial. Lancet 2019; 394 (10212): 1940-1948
    CrossrefPubMedGoogle Scholar
  • 8 Barry PJ, Mall MA, Álvarez A. et al; VX18-445-104 Study Group. Triple therapy for cystic fibrosis Phe508del-gating and -residual function genotypes. N Engl J Med 2021; 385 (09) 815-825
    CrossrefPubMedGoogle Scholar
  • 9 Peckham D, Etherington C, White H. et al. The development and deployment of integrated electronic care records in a regional adult and paediatric cystic fibrosis unit. J Cyst Fibros 2014; 13 (06) 681-686
    CrossrefPubMedGoogle Scholar
  • 10 Hussain SA, Sezgin E, Krivchenia K, Luna J, Rust S, Huang Y. A natural language processing pipeline to synthesize patient-generated notes toward improving remote care and chronic disease management: a cystic fibrosis case study. JAMIA Open 2021; 4 (03) ooab084
    CrossrefPubMedGoogle Scholar
  • 11 White H, Shaw N, Denman S, Pollard K, Wynne S, Peckham DG. Variation in lung function as a marker of adherence to oral and inhaled medication in cystic fibrosis. Eur Respir J 2017; 49 (03) 1600987
    CrossrefPubMedGoogle Scholar
  • 12 Wainwright CE, Tullis E. Electronic care records—can they fulfil their promise?. J Cyst Fibros 2014; 13 (06) 608-609
    CrossrefPubMedGoogle Scholar
  • 13 Eakin MN, Riekert KA. The impact of medication adherence on lung health outcomes in cystic fibrosis. Curr Opin Pulm Med 2013; 19 (06) 687-691
    CrossrefPubMedGoogle Scholar
  • 14 Daniels T, Goodacre L, Sutton C, Pollard K, Conway S, Peckham D. Accurate assessment of adherence: self-report and clinician report vs electronic monitoring of nebulizers. Chest 2011; 140 (02) 425-432
    CrossrefPubMedGoogle Scholar
  • 15 Ball R, Southern KW, McCormack P, Duff AJA, Brownlee KG, McNamara PS. Adherence to nebulised therapies in adolescents with cystic fibrosis is best on week-days during school term-time. J Cyst Fibros 2013; 12 (05) 440-444
    CrossrefPubMedGoogle Scholar
  • 16 Raywood E, Douglas H, Kapoor K. et al. Protocol for Project Fizzyo, an analytic longitudinal observational cohort study of physiotherapy for children and young people with cystic fibrosis, with interrupted time-series design. BMJ Open 2020; 10 (10) e039587
    CrossrefPubMedGoogle Scholar
  • 17 Arden MA, Hutchings M, Whelan P. et al. Development of an intervention to increase adherence to nebuliser treatment in adults with cystic fibrosis: CFHealthHub. Pilot Feasibility Stud 2021; 7 (01) 1
    CrossrefPubMedGoogle Scholar
  • 18 Hoo ZH, Totton N, Waterhouse S. et al. Real-world adherence among adults with cystic fibrosis is low: a retrospective analysis of the CFHealthHub Digital Learning Health System. Chest 2021; 160 (06) 2061-2065
    CrossrefPubMedGoogle Scholar
  • 19 Wood J, Mulrennan S, Hill K, Cecins N, Morey S, Jenkins S. Telehealth clinics increase access to care for adults with cystic fibrosis living in rural and remote Western Australia. J Telemed Telecare 2017; 23 (07) 673-679
    CrossrefPubMedGoogle Scholar
  • 20 Gur M, Nir V, Teleshov A. et al. The use of telehealth (text messaging and video communications) in patients with cystic fibrosis: a pilot study. J Telemed Telecare 2017; 23 (04) 489-493
    CrossrefPubMedGoogle Scholar
  • 21 Gifford AH, Ong T, Dowd C. et al. Evaluating barriers to and promoters of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs. J Cyst Fibros 2021; 20 (3, Suppl 3): 9-13
    CrossrefPubMedGoogle Scholar
  • 22 Albon D, Thomas L, Hoberg L. et al; CF Learning Network telehealth iLab working group. Cystic fibrosis learning network telehealth innovation lab during the COVID-19 pandemic: a success QI story for interdisciplinary care and agenda setting. BMJ Open Qual 2022; 11 (02) e001844
    CrossrefPubMedGoogle Scholar
  • 23 Etherington C, Conway S, Peckham D. The role of electronic patient records (EPR) in improving service efficiency and clinical performance in a regional adult UK centre. J Cyst Fibros 2011; 10 (01) S96
    CrossrefPubMedGoogle Scholar
  • 24 Spoletini G, Campbel C, Etherington C. et al. Evolving cystic fibrosis care during COVID-19: a single-centre experience. J Cyst Fibros 2022; 21 (01) S53
    CrossrefPubMedGoogle Scholar
  • 25 Perkins RC, Davis J, NeSmith A. et al. Favorable clinician acceptability of telehealth as part of the cystic fibrosis care model during the COVID-19 pandemic. Ann Am Thorac Soc 2021; 18 (09) 1588-1592
    CrossrefPubMedGoogle Scholar
  • 26 Solomon GM, Bailey J, Lawlor J. et al. Patient and family experience of telehealth care delivery as part of the CF chronic care model early in the COVID-19 pandemic. J Cyst Fibros 2021; 20 (3, suppl 3): 41-46
    CrossrefPubMedGoogle Scholar
  • 27 Beşer ÖF, Karaboğa EPU, Hepkaya E. et al. The role of telehealth services in children with cystic fibrosis during coronavirus disease 2019 outbreak. Telemed J E Health 2022; 28 (06) 832-837
    PubMedGoogle Scholar
  • 28 Edmondson C, Westrupp N, Seddon P. et al. The feasibility of home monitoring of young people with cystic fibrosis: results from CLIMB-CF. J Cyst Fibros 2022; 21 (01) 70-77
    CrossrefPubMedGoogle Scholar
  • 29 Hendra K, Neemuchwala F, Chan M, Ly NP, Gibb ER. Patient and provider experience with cystic fibrosis telemedicine clinic. Front Pediatr 2021; 9: 784692
    CrossrefPubMedGoogle Scholar
  • 30 Hatziagorou E, Toulia I, Avramidou V, Kampouras A, Tsara V, Tsanakas J. Change in CF care during COVID-19 pandemic: single-center experience in a middle-income setting. Pediatr Pulmonol 2021; 56 (09) 3065-3067
    CrossrefPubMedGoogle Scholar
  • 31 Cox NS, Alison JA, Rasekaba T, Holland AE. Telehealth in cystic fibrosis: a systematic review. J Telemed Telecare 2012; 18 (02) 72-78
    CrossrefPubMedGoogle Scholar
  • 32 Hamilton JL, Snuggerud AE, Meihls SM, Toledo H, Stewart J. Quality improvement and rapid PDSA cycles to maintain routine surveillance of pulmonary pathogens during the COVID-19 pandemic in a pediatric cystic fibrosis clinic. J Pediatr Nurs 2022; 63: 131-135
    CrossrefPubMedGoogle Scholar
  • 33 Ong T, Van Citters AD, Dowd C. et al. Remote monitoring in telehealth care delivery across the U.S. cystic fibrosis care network. J Cyst Fibros 2021; 20 (3, Suppl 3): 57-63
    CrossrefPubMedGoogle Scholar
  • 34 Muhlebach MS, Cunningham F, LiPuma JJ, Zhou JJ, Saiman L. Impact of the SARS-CoV-2 pandemic on cystic fibrosis centres and care: survey results from US centres. ERJ Open Res 2021; 7 (04) 00249-2021
    CrossrefPubMedGoogle Scholar
  • 35 Franciosi AN, Wilcox PG, Quon BS. Cystic fibrosis respiratory microbiology monitoring during a global pandemic: lessons learned from a shift to telehealth. Ann Am Thorac Soc 2022; 19 (03) 498-500
    CrossrefPubMedGoogle Scholar
  • 36 Bouzek DC, Ren CL, Thompson M, Slaven JE, Sanders DB. Evaluating FEV1 decline in diagnosis and management of pulmonary exacerbations in children with cystic fibrosis. Pediatr Pulmonol 2022; 57 (07) 1709-1716
    CrossrefPubMedGoogle Scholar
  • 37 Paynter A, Khan U, Heltshe SL, Goss CH, Lechtzin N, Hamblett NM. A comparison of clinic and home spirometry as longtudinal outcomes in cystic fibrosis. J Cyst Fibros 2022; 21 (01) 78-83
    CrossrefPubMedGoogle Scholar
  • 38 Bell JM, Sivam S, Dentice RL. et al. Quality of home spirometry performance amongst adults with cystic fibrosis. J Cyst Fibros 2022; 21 (01) 84-87
    CrossrefPubMedGoogle Scholar
  • 39 Morimoto Y, Takahashi T, Sawa R. et al. Web portals for patients with chronic diseases: scoping review of the functional features and theoretical frameworks of telerehabilitation platforms. J Med Internet Res 2022; 24 (01) e27759
    CrossrefPubMedGoogle Scholar
  • 40 Milligan CM, Pollard K, Watson R. et al. Physiotherapist-led online exercise session for people with cystic fibrosis (CF) during the COVID-19 pandemic: a service evaluation. Thorax 2021; 76 (01) A134
    PubMedGoogle Scholar
  • 41 Tomlinson OW, Shelley J, Trott J, Bowhay B, Chauhan R, Sheldon CD. The feasibility of online video calling to engage patients with cystic fibrosis in exercise training. J Telemed Telecare 2020; 26 (06) 356-364
    CrossrefPubMedGoogle Scholar
  • 42 Hillen B, Simon P, Schlotter S. et al. Feasibility and implementation of a personalized, web-based exercise intervention for people with cystic fibrosis for 1 year. BMC Sports Sci Med Rehabil 2021; 13 (01) 95
    CrossrefPubMedGoogle Scholar
  • 43 Cox NS, Alison JA, Button BM, Wilson JW, Holland AE. Assessing exercise capacity using telehealth: a feasibility study in adults with cystic fibrosis. Respir Care 2013; 58 (02) 286-290
    CrossrefPubMedGoogle Scholar
  • 44 Huhn S, Axt M, Gunga HC. et al. The impact of wearable technologies in health research: scoping review. JMIR Mhealth Uhealth 2022; 10 (01) e34384
    CrossrefPubMedGoogle Scholar
  • 45 Shelley J, Fairclough SJ, Knowles ZR. et al. A formative study exploring perceptions of physical activity and physical activity monitoring among children and young people with cystic fibrosis and health care professionals. BMC Pediatr 2018; 18 (01) 335
    CrossrefPubMedGoogle Scholar
  • 46 Curran M, Tierney A, Collins L. et al. Accuracy of the ActivPAL and Fitbit Charge 2 in measuring step count in cystic fibrosis. Physiother Theory Pract 2021; 8: 1-11
    PubMedGoogle Scholar
  • 47 Gaynor M, Sawyer A, Jenkins S, Wood J. Variable agreement between wearable heart rate monitors during exercise in cystic fibrosis. ERJ Open Res 2019; 5 (04) 00006-2019
    CrossrefPubMedGoogle Scholar
  • 48 Savi D, Graziano L, Giordani B. et al. New strategies of physical activity assessment in cystic fibrosis: a pilot study. BMC Pulm Med 2020; 20 (01) 285
    CrossrefPubMedGoogle Scholar
  • 49 G S, L G, K P, et al. Dose adjustments of elexacaftor/tezacaftor/ivacaftor in response to mental health side effects in adults with cystic fibrosis. J Cyst Fibros 2022; (e-pub ahead of print) DOI: 10.1016/j.jcf.2022.05.001.
    CrossrefPubMedGoogle Scholar
  • 50 Gonska T. The sweat chloride test has lived up to the changes in CF care. J Cyst Fibros 2022; 21 (03) 381-382
    CrossrefPubMedGoogle Scholar
  • 51 Choi DH, Kitchen GB, Jennings MT, Cutting GR, Searson PC. Out-of-clinic measurement of sweat chloride using a wearable sensor during low-intensity exercise. NPJ Digit Med 2020; 3: 49
    CrossrefPubMedGoogle Scholar
  • 52 Choi DH, Thaxton A, Jeong IC. et al. Sweat test for cystic fibrosis: wearable sweat sensor vs. standard laboratory test. J Cyst Fibros 2018; 17 (04) e35-e38
    CrossrefPubMedGoogle Scholar
  • 53 Tabasum H, Gill N, Mishra R, Lone S. Wearable microfluidic-based e-skin sweat sensors. RSC Advances 2022; 12 (14) 8691-8707
    CrossrefPubMedGoogle Scholar
  • 54 Relf R, Willmott A, Flint MS, Beale L, Maxwell N. Reliability of a wearable sweat rate monitor and routine sweat analysis techniques under heat stress in females. J Therm Biol 2019; 79: 209-217
    CrossrefPubMedGoogle Scholar
  • 55 Timpel P, Oswald S, Schwarz PEH, Harst L. Mapping the evidence on the effectiveness of telemedicine interventions in diabetes, dyslipidemia, and hypertension: an umbrella review of systematic reviews and meta-analyses. J Med Internet Res 2020; 22 (03) e16791
    CrossrefPubMedGoogle Scholar
  • 56 Scully KJ, Sherwood JS, Martin K. et al. Continuous glucose monitoring and HbA1c in cystic fibrosis: clinical correlations and implications for CFRD diagnosis. J Clin Endocrinol Metab 2022; 107 (04) e1444-e1454
    CrossrefPubMedGoogle Scholar
  • 57 Gojsina B, Minic P, Todorovic S, Soldatovic I, Sovtic A. Continuous glucose monitoring as a valuable tool in the early detection of diabetes related to cystic fibrosis. Front Pediatr 2021; 9: 659728
    CrossrefPubMedGoogle Scholar
  • 58 Marks BE, Williams KM, Sherwood JS, Putman MS. Practical aspects of diabetes technology use: continuous glucose monitors, insulin pumps, and automated insulin delivery systems. J Clin Transl Endocrinol 2021; 27: 100282
    PubMedGoogle Scholar
  • 59 Ahmed R, Greenfield M, Morley CP, Desimone M. Satisfaction and concerns with telemedicine endocrine care of patients with cystic fibrosis. Telemed Rep 2022; 3 (01) 93-100
    PubMedGoogle Scholar
  • 60 Shimmin D, Mansfield M, Taylor K. et al. Early experience of flash glucose monitoring using the Freestyle Libre System in adults with Cystic Fibrosis-Related Diabetes (CFRD) attending a large regional UK centre. J Cyst Fibros 2000; 19 (02) S26
    PubMedGoogle Scholar
  • 61 Frost F, Dyce P, Nazareth D, Malone V, Walshaw MJ. Continuous glucose monitoring guided insulin therapy is associated with improved clinical outcomes in cystic fibrosis-related diabetes. J Cyst Fibros 2018; 17 (06) 798-803
    CrossrefPubMedGoogle Scholar
  • 62 Jaclyn D, Andrew N, Ryan P. et al. Patient and family perceptions of telehealth as part of the cystic fibrosis care model during COVID-19. J Cyst Fibros 2021; 20 (03) e23-e28
    CrossrefPubMedGoogle Scholar
  • 63 Thee S, Stahl M, Fischer R. et al. A multi-centre, randomized, controlled trial on coaching and telemonitoring in patients with cystic fibrosis: conneCT CF. BMC Pulm Med 2021; 21 (01) 131
    CrossrefPubMedGoogle Scholar
  • 64 Lang RL, Wilson C, Stockton K, Russell T, Johnston LM. CyFiT telehealth: protocol for a randomised controlled trial of an online outpatient physiotherapy service for children with cystic fibrosis. BMC Pulm Med 2019; 19 (01) 21
    CrossrefPubMedGoogle Scholar
  • 65 Nash EF, Choyce J, Carrolan V. et al. A prospective randomised controlled mixed-methods pilot study of home monitoring in adults with cystic fibrosis. Ther Adv Respir Dis 2022; 16: 17 534666211070133
    PubMedGoogle Scholar
  • 66 Van Citters AD, Dieni O, Scalia P. et al. Barriers and facilitators to implementing telehealth services during the COVID-19 pandemic: a qualitative analysis of interviews with cystic fibrosis care team members. J Cyst Fibros 2021; 20 (3, Suppl 3): 23-28
    CrossrefPubMedGoogle Scholar
  • 67 Albon D, Van Citters AD, Ong T. et al. Telehealth use in cystic fibrosis during COVID-19: association with race, ethnicity, and socioeconomic factors. J Cyst Fibros 2021; 20 (3, Suppl 3): 49-54
    CrossrefPubMedGoogle Scholar
  • 68 Garcia B, Christon L, Gray S. MUSC Adult CF Program. In the south, if you give us lemons, we will make you lemonade. J Cyst Fibros 2020; 19 (05) 842-843
    CrossrefPubMedGoogle Scholar